Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage

Go back to Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage
(NASDAQ: ERNA) Delayed: 4.31 --0 (-0%)
Previous Close $4.31    52 Week High
Open $4.31    52 Week Low
Day High $4.31    P/E N/A 
Day Low $4.31    EPS
Volume 11       

(NASDAQ: ERNA) Delayed: 4.31 --0 (-0%)
Previous Close $4.31    52 Week High
Open $4.31    52 Week Low
Day High $4.31    P/E N/A 
Day Low $4.31    EPS
Volume 11       

RYDEX 2X S&P SELECT SECTOR FINANCIAL ETF (NYSE: RFL) Delayed: 2.56 --0 (-0%)
Previous Close $2.56    52 Week High $17.54 
Open $2.56    52 Week Low $0.15 
Day High $2.56    P/E N/A 
Day Low $2.56    EPS $0.00 
Volume 5,636